These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 19562219)
1. A methodology for quantitation and characterization of oligonucleotides in albumin microspheres. Uddin MN; Do DP; Pai SB; Gayakwad S; Oettinger CW; D'Souza MJ Analyst; 2009 Jul; 134(7):1483-9. PubMed ID: 19562219 [TBL] [Abstract][Full Text] [Related]
2. Formulation and in vitro characterization of spray-dried antisense oligonucleotide to NF-kappaB encapsulated albumin microspheres. Gayakwad SG; Bejugam NK; Akhavein N; Uddin NA; Oettinger CE; D'Souza MJ J Microencapsul; 2009 Dec; 26(8):692-700. PubMed ID: 19888878 [TBL] [Abstract][Full Text] [Related]
4. Enhanced intracellular uptake and inhibition of NF-kappaB activation by decoy oligonucleotide released from PLGA microspheres. De Rosa G; Maiuri MC; Ungaro F; De Stefano D; Quaglia F; La Rotonda MI; Carnuccio R J Gene Med; 2005 Jun; 7(6):771-81. PubMed ID: 15702489 [TBL] [Abstract][Full Text] [Related]
5. pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres. Quan JS; Jiang HL; Kim EM; Jeong HJ; Choi YJ; Guo DD; Yoo MK; Lee HG; Cho CS Int J Pharm; 2008 Jul; 359(1-2):205-10. PubMed ID: 18490120 [TBL] [Abstract][Full Text] [Related]
6. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro. Lewis KJ; Irwin WJ; Akhtar S J Drug Target; 1998; 5(4):291-302. PubMed ID: 9713978 [TBL] [Abstract][Full Text] [Related]
7. Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain. Khan A; Sommer W; Fuxe K; Akhtar S J Drug Target; 2000; 8(5):319-34. PubMed ID: 11328659 [TBL] [Abstract][Full Text] [Related]
8. The effect of antisense to NF-κB in an albumin microsphere formulation on the progression of left-ventricular remodeling associated with chronic volume overload in rats. Patel N; Addo RT; Ubale R; Uddin MN; D'Souza M; Jobe L J Drug Target; 2014 Nov; 22(9):796-804. PubMed ID: 24892743 [TBL] [Abstract][Full Text] [Related]
9. Improvement of recipient survival after small size graft liver transplantation in rats with preischemic manipulation or administering antisense against nuclear factor-kappaB. Qian JM; Zhang H; Wu XF; Li GQ; Chen XP; Wu J Transpl Int; 2007 Sep; 20(9):784-9. PubMed ID: 17535306 [TBL] [Abstract][Full Text] [Related]
11. The effect of intracellular delivery of catalase and antisense oligonucleotides to NF-kappaB using albumin microcapsules in the endotoxic shock model. Siwale RC; Oettinger CW; Addo R; Siddig A; D'Souza MJ J Drug Target; 2009 Nov; 17(9):701-9. PubMed ID: 19845486 [TBL] [Abstract][Full Text] [Related]
12. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides. Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187 [TBL] [Abstract][Full Text] [Related]
13. [Transfection of nuclear factor-kappaB decoy oligodeoxynucleotides prevents ischemic acute renal failure in rats]. Cao CC; Ding XQ; Ou ZL; Liu CF; Li P; Wang L; Zhu CF Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1597-602. PubMed ID: 14642117 [TBL] [Abstract][Full Text] [Related]
14. Encapsulation, stabilization, and release of BSA-FITC from polyanhydride microspheres. Determan AS; Trewyn BG; Lin VS; Nilsen-Hamilton M; Narasimhan B J Control Release; 2004 Nov; 100(1):97-109. PubMed ID: 15491814 [TBL] [Abstract][Full Text] [Related]
15. Characterization of interaction between cationic lipid-oligonucleotide complexes and cellular membrane lipids using confocal imaging and fluorescence correlation spectroscopy. Gordon SP; Berezhna S; Scherfeld D; Kahya N; Schwille P Biophys J; 2005 Jan; 88(1):305-16. PubMed ID: 15516528 [TBL] [Abstract][Full Text] [Related]
16. Gel and solid matrix systems for the controlled delivery of drug carrier-associated nucleic acids. Fattal E; De Rosa G; Bochot A Int J Pharm; 2004 Jun; 277(1-2):25-30. PubMed ID: 15158966 [TBL] [Abstract][Full Text] [Related]
17. Opsonized erythrocyte ghosts for liver-targeted delivery of antisense oligodeoxynucleotides. Kim SH; Kim EJ; Hou JH; Kim JM; Choi HG; Shim CK; Oh YK Biomaterials; 2009 Feb; 30(5):959-67. PubMed ID: 19027156 [TBL] [Abstract][Full Text] [Related]
18. Sustained release of nanosized complexes of polyethylenimine and anti-TGF-beta 2 oligonucleotide improves the outcome of glaucoma surgery. Gomes dos Santos AL; Bochot A; Doyle A; Tsapis N; Siepmann J; Siepmann F; Schmaler J; Besnard M; Behar-Cohen F; Fattal E J Control Release; 2006 May; 112(3):369-81. PubMed ID: 16644054 [TBL] [Abstract][Full Text] [Related]
19. Enhanced bioavailability of orally administered antisense oligonucleotide to nuclear factor kappa B mRNA after microencapsulation with albumin. Uddin MN; Patel NJ; Bhowmik T; D'Souza B; Akalkotkar A; Etzlar F; Oettinger CW; D'Souza M J Drug Target; 2013 May; 21(5):450-7. PubMed ID: 23480723 [TBL] [Abstract][Full Text] [Related]
20. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres. Kim JH; Taluja A; Knutson K; Han Bae Y J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]